Chiariello Giovanni A, Nesta Marialisa, Bruno Piergiorgio, Pasquini Annalisa, Ferraro Francesco, Cammertoni Federico, Marano Riccardo, Colizzi Christian, Farina Piero, D'Amario Domenico, Trani Carlo, Massetti Massimo
1 Cardiovascular Sciences Department, Foundation Polyclinic University A. Gemelli IRCCS, Rome, Italy.
2 Catholic University of The Sacred Heart, Rome, Italy.
Innovations (Phila). 2019 Aug;14(4):369-373. doi: 10.1177/1556984519858919. Epub 2019 Jun 27.
Surgical ventricular reconstruction (SVR) is the therapy of choice for patients with left ventricular dilatation, apical and anterolateral transmural scar, and low ejection fraction. STICH trial did not show that SVR led to improved survival but several observational studies did. However, because of the considerable operative risk, open heart surgery is considered risky in debilitated patients and clinical results are controversial. Alternative less invasive strategies for left ventricular aneurysm repair have been proposed. We present a case of a left ventricular aneurysm repair using the less invasive ventricular enhancement technique (LIVE) with the Revivent TC system (BioVentrix Inc., San Ramon, CA) in a totally surgical approach, instead of a hybrid interventional-surgical one, as previously described.
外科心室重建术（SVR）是左心室扩张、心尖及前外侧透壁瘢痕且射血分数低的患者的首选治疗方法。STICH试验并未表明SVR能提高生存率，但多项观察性研究表明可以。然而，由于手术风险相当大，心脏直视手术在身体虚弱的患者中被认为具有风险，且临床结果存在争议。已经提出了用于左心室动脉瘤修复的替代性微创策略。我们介绍了一例使用Revivent TC系统（加利福尼亚州圣拉蒙市BioVentrix公司）的微创心室增强技术（LIVE）进行左心室动脉瘤修复的病例，该病例采用的是完全外科手术方法，而非如先前所述的介入-外科混合方法。
